Status:
UNKNOWN
The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment
Lead Sponsor:
University of Calgary
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Chemotherapy treatment (CT) can have burdensome side effects such as fatigue, nausea-vomiting, and sleep problems that can significantly affect patients' quality of life. Fatigue is the mo...
Eligibility Criteria
Inclusion
- Men and women over the age of 18
- Diagnosed with either a) stage I-III HER 2 normal breast carcinoma or b) Stage II-III colorectal carcinoma
- Scheduled to undergo either neoadjuvant or adjuvant: a) FEC- D or AC-T chemotherapy or b) FOLFOX or CAPEOX chemotherapy
- Weekly access to high-speed internet
- Access to a computer/tablet/smart phone
- Able to attend MBCR classes at scheduled times
- Sufficient ability to speak and read English
- Willingness to be randomized into immediate or waitlist groups and complete all assessments
Exclusion
- Metastatic patients
- Suffering from current Major Depressive Disorder, Bipolar Disorder or other psychiatric disorder (self-report)
- Currently engaging in meditation one or more times per week within the previous year.
- Participation in an MBCR or MBSR program in the last five years.
- Cognitive impairment (\>6 on the Brief Screen for Cognitive Impairment)
- Physical functional impairment that would interfere with the ability to participate in the intervention (on the PAR-Q questionnaire)
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT03484000
Start Date
June 1 2018
End Date
January 1 2025
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N3C1